Other

Dataset Information

1K

Signalling Inhibition by Ponatinib Disrupts Productive Alternative Lengthening of Telomeres (ALT)


ABSTRACT: Alternative lengthening of telomeres (ALT) supports telomere maintenance and replicative immortality in around 10-15% of cancers, thus representing a compelling target for therapy.To identify anti-cancer drugs that can be repurposed as ALT-centered therapies, we performed for a compound library screen on isogenic cell lines that rely either on telomerase or ALT mechanisms. We validated candidates on a panel of ALT- vs. telomerase-positive sarcoma cells and assessed levels of extrachromosomal telomeric C-circles after drug treatment, as a bona fide marker of ALT activity. We identified a receptor tyrosine kinase inhibitor ponatinib that deregulated ALT mechanisms, increased telomeric replicative stress and induced telomeric dysfunction in ALT cells. Using a model of ALT sarcoma xenografts, we found that ponatinib targeted ALT-positive cells and mitigated telomere elongation in these tumors. To identify the mode of action of ponatinib on ALT, we performed RNA-sequencing and quantitative proteomic and phosphoproteomic analyses, and shortlisted candidates to test the effect of their loss on telomeric C-circle levels. We identified an ABL1-JNK-JUN signalling circuit to be inhibited by ponatinib and to have a role in suppressing extrachromosomal telomeric C-circle formation. Furthermore, transcriptome and interactome analyses of JUN suggested a role of JUN in DNA damage repair pathways, independently of its capacity as a transcription factor. These results were corroborated by new synergistic drug interactions between ponatinib and either DNA synthesis or repair inhibitors such as triciribine and KU-60019, respectively. Overall, we identified a novel signalling pathway impacting ALT which can be targeted by a clinically approved kinase inhibitor.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

DISEASE(S): Osteosarcoma

SUBMITTER: Dennis Kappei  

LAB HEAD: Dennis Kappei

PROVIDER: PXD032188 | Pride | 2022-03-14

REPOSITORIES: Pride

Similar Datasets

2023-02-20 | PXD037501 | Pride
2020-07-17 | MSV000085772 | MassIVE
2022-07-01 | GSE134135 | GEO
2023-03-08 | PXD038235 | Pride
2022-09-28 | PXD028882 | Pride
2010-05-04 | GSE17118 | GEO
2012-01-17 | E-GEOD-35044 | biostudies-arrayexpress
| PRJNA554016 | ENA
2019-09-16 | E-MTAB-8248 | biostudies-arrayexpress
2015-02-23 | E-GEOD-46237 | biostudies-arrayexpress